← Back to Search

Artificial Pancreas

NAP first, then UMPC for Type 1 Diabetes (NAP Trial)

N/A
Waitlist Available
Led By Sue A Brown, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 hours (two 18-hour experiments)
Awards & highlights

NAP Trial Summary

This trial assesses a Neural-net Artificial Pancreas (NAP) compared to an established algorithm in 20 people with diabetes. It aims to compare health outcomes and complete results with 15 participants.

Eligible Conditions
  • Type 1 Diabetes

NAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 hours (two 18-hour experiments)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 hours (two 18-hour experiments) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Time-in-Range (TIR) on NAP versus UMPC.
Secondary outcome measures
Participant Feedback
Percent of Time in Hyperglycemia.
Percent of Time in Hypoglycemia.
+1 more

NAP Trial Design

2Treatment groups
Experimental Treatment
Group I: UMPC first, then NAPExperimental Treatment2 Interventions
Participants will use the UMPC for 18 hours, then switch to NAP for 18 hours.
Group II: NAP first, then UMPCExperimental Treatment2 Interventions
Participants will use the Neural Net Artificial Pancreas (NAP) algorithm for 18 hours. Then switch to the University of Virginia Model-Predictive Control (UMPC) for 18 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
University of Virginia Model Predictive Control
2023
N/A
~20
Neural-net Artificial Pancreas
2023
N/A
~20

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,245,016 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,315,051 Total Patients Enrolled
Boris P Kovatchev, PhDStudy DirectorUniversity of Virginia Center for Diabetes Technology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment still accepting volunteers?

"Data from clinicaltrials.gov suggests that this medical trial is not currently recruiting participants. The initial posting was on May 1st, 2023 and the most recent update occured on 16th of the same month. However, there are 388 other trials open for enrollment at present time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Neural-net Artificial Pancreas (NAP)
Boris Kovatchev, PhD 2023. "Neural-net Artificial Pancreas (NAP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05876273.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top